| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Re.7S |
| Molecular Weight | 596.365 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | -14 |
SHOW SMILES / InChI
SMILES
[S--].[S--].[S--].[S--].[S--].[S--].[S--].[186Re].[186Re]
InChI
InChIKey=USBWXQYIYZPMMN-CLJOKXJZSA-N
InChI=1S/2Re.7S/q;;7*-2/i2*1+0;;;;;;;
| Molecular Formula | Re |
| Molecular Weight | 185.954986529 |
| Charge | 0 |
| Count |
MOL RATIO
2 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2S |
| Molecular Weight | 34.081 |
| Charge | 0 |
| Count |
MOL RATIO
7 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Rhenium Re-186 is radioisotope of rhenium. It is produced in many nuclear reactors throughout the world, and the 90-hour half-life can often permit distribution to sites distant from the production facilities. Re-186 decays with emission of beta-particles which have a range of up to 4.5 mm in tissues. Rhenium-186 complex with 1-hydroxy-ethylidene-1,1 diphosphonic acid (HEDP) is used for palliative treatment of bone metastases originating from breast or prostate cancer. Re-186-labeled sulfur colloid particles are used for the therapy of rheumatoid arthritis of the synovial joints.
